These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7489314)

  • 1. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy.
    Knopp MV; Brix G; Junkermann HJ; Sinn HP
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):633-58. PubMed ID: 7489314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Pickles MD; Lowry M; Manton DJ; Gibbs P; Turnbull LW
    Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of dynamic contrast-enhanced MR mammography imaging in the diagnosis of breast tumors].
    Iakovleva EK; Tiutin LA; Tikhova KE; Pozdniakov AV; Shelkoplias EN
    Vopr Onkol; 2008; 54(4):445-51. PubMed ID: 18942398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment.
    Li SP; Padhani AR; Makris A
    J Natl Cancer Inst Monogr; 2011; 2011(43):103-7. PubMed ID: 22043053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of dynamic contrast-enhanced magnetic resonance imaging in evaluating clinical responses to neoadjuvant chemotherapy in breast cancer.
    Liu YH; Ye JM; Xu L; Huang QY; Zhao JX; Duan XN; Qin NS; Wang XY
    Chin Med J (Engl); 2011 Jan; 124(2):194-8. PubMed ID: 21362364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Response evaluation with functional magnetic resonance mammography].
    Knopp M
    Zentralbl Gynakol; 1996; 118(10):571-2. PubMed ID: 8999711
    [No Abstract]   [Full Text] [Related]  

  • 9. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.
    Hylton N
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):383-9, vii. PubMed ID: 17098179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?
    Heldahl MG; Lundgren S; Jensen LR; Gribbestad IS; Bathen TF
    J Magn Reson Imaging; 2011 Sep; 34(3):547-56. PubMed ID: 21761463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
    Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
    Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamentals of quantitative dynamic contrast-enhanced MR imaging.
    Paldino MJ; Barboriak DP
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):277-89. PubMed ID: 19406359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
    Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of breast cancer response to neoadjuvant chemotherapy: is volumetric MRI a reliable tool?
    Lorenzon M; Zuiani C; Londero V; Linda A; Furlan A; Bazzocchi M
    Eur J Radiol; 2009 Jul; 71(1):82-8. PubMed ID: 18472240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
    Su MY; Baik HM; Yu HJ; Chen JH; Mehta RS; Nalcioglu O
    Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging.
    Padhani AR; Leach MO
    Abdom Imaging; 2005; 30(3):324-41. PubMed ID: 15688112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy.
    Martincich L; Montemurro F; Cirillo S; Marra V; De Rosa G; Ponzone R; Aglietta M; Regge D
    Radiol Med; 2003; 106(1-2):51-8. PubMed ID: 12951551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of mammography, ultrasonography and magnetic resonance imaging in the detection of intraductal spread of breast cancer following neoadjuvant chemotherapy.
    Kubota K; Ogawa Y; Nishioka A; Kariya S; Itoh S; Murata Y; Hamada N; Maeda H; Tanaka Y
    Oncol Rep; 2007 Apr; 17(4):915-8. PubMed ID: 17342336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.